Previous close | 0.4800 |
Open | 0.5374 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.4458 - 0.5374 |
52-week range | 0.2000 - 1.1150 |
Volume | |
Avg. volume | 1,115,303 |
Market cap | 4.346M |
Beta (5Y monthly) | 1.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | -5.0100 |
Earnings date | 27 May 2024 - 01 Jun 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DENVER, May 17, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that management has rescheduled the joint corporate update call with Danam for Wednesday, May 22, 2024 at 4:00 PM Eastern Time. Conference Call InformationDate: Wednesday, May 22, 2024Time: 4:00 PM Eastern TimeToll Free: 1-877-545-0523International: 1-973-528-0016Participant Access Code: 229
DENVER, May 16, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today it received a written notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that it has granted the Company an extension to regain compliance with the continued listing requirements for The Nasdaq Capital Market (the “Panel Decis
DENVER, May 16, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that at its adjourned Special Shareholder Meeting held on May 14, 2024, shareholders approved the proposal to amend the Company’s Articles of Incorporation, to increase the number of authorized shares of common stock of the Company from 9,000,000 to 250,000,000. The Company intends to file t